Definitive Radiation Therapy for Ewing Sarcoma: Outcomes Based on Tumor Volume, Dose, and Fractionation
Purpose: Dose escalation for definitive radiation therapy (DE-RT) in larger Ewing sarcomas (ESs) is associated with a lower risk of local recurrence. We report treatment and toxicity outcomes in ES tumors treated with DE-RT, including hypofractionated approaches and size stratification of analysis....
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-08-01
|
| Series: | Advances in Radiation Oncology |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2452109425001071 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Purpose: Dose escalation for definitive radiation therapy (DE-RT) in larger Ewing sarcomas (ESs) is associated with a lower risk of local recurrence. We report treatment and toxicity outcomes in ES tumors treated with DE-RT, including hypofractionated approaches and size stratification of analysis. Methods and Materials: A retrospective review of ES patients treated with DE-RT to doses ≥55.8 Gy was performed. Local failure (LF) with death as a competing risk was assessed. Maximally selected rank statistics were used to determine the optimal stratification of patients by survival using tumor size measurements. Results: In total, 47 patients were analyzed. Twenty-eight patients (59.6%) received DE-RT, of which 6 received hypofractionation. For DE-RT, median equivalent dose in 2 Gy fraction for α/β = 10 was 60 Gy (range, 56.2-62) with conventional fractionation and 62.2 Gy (range, 56.5-67.1) with hypofractionation. Empirically derived size cutoffs identified a subgroup of ultralarge tumors at higher risk of LF defined as >11.8 cm in the longest direction, 569.2 cm3 prechemotherapy volume, or 288.9 cm3 postchemotherapy volume. Five-year cumulative incidence of LF was lower in patients treated with DE-RT at 11.7% (95% CI, 3.16%-43.6%) versus 35.6% for non-DE-RT (95% CI, 17.4%-72.61%; P = .098). Multivariate analysis showed trends toward DE-RT benefiting tumors of all sizes and stages. Conclusions: DE-RT was associated with a trend toward better LF in all tumors without toxicity or plan quality changes. Ultralarge tumors demonstrated poor LF rates and necessitate further study. |
|---|---|
| ISSN: | 2452-1094 |